Form D — Atommap Corp
0002001012-26-000003 · filed Mar 20, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $59,630,328
- Reported amount sold
- $31,130,335
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Atommap Corp
- CIK
- 2001012
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1059 3RD AVENUE
NEW YORK, New York 10065 - Phone
- 9179688176
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Huafeng Xu · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Keith Loebner · DirectorNew York, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗